APA (7th ed.) Citation

Abdelmonem, R., Al-Samadi, I. E. I., El Nashar, R. M., Jasti, B. R., & El-Nabarawi, M. A. (2022). Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: Statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Drug Delivery, 29(1), 2868. https://doi.org/10.1080/10717544.2022.2115164

Chicago Style (17th ed.) Citation

Abdelmonem, Rehab, Inas Essam Ibrahim Al-Samadi, Rasha M. El Nashar, Bhaskara R. Jasti, and Mohamed A. El-Nabarawi. "Fabrication of Nanostructured Lipid Carriers Ocugel for Enhancing Loratadine Used in Treatment of COVID-19 Related Symptoms: Statistical Optimization, In-vitro, Ex-vivo, and In-vivo Studies Evaluation." Drug Delivery 29, no. 1 (2022): 2868. https://doi.org/10.1080/10717544.2022.2115164.

MLA (9th ed.) Citation

Abdelmonem, Rehab, et al. "Fabrication of Nanostructured Lipid Carriers Ocugel for Enhancing Loratadine Used in Treatment of COVID-19 Related Symptoms: Statistical Optimization, In-vitro, Ex-vivo, and In-vivo Studies Evaluation." Drug Delivery, vol. 29, no. 1, 2022, p. 2868, https://doi.org/10.1080/10717544.2022.2115164.